第一作者单位：[1]Shandong Canc Hosp, Dept Radiat Oncol, Jinan, Shandong, Peoples R China
推荐引用方式(GB/T 7714)：
Zhang N.,Yang M.,Zhang L.,et al.The functional MDM4 genetic variant is associated with clinical outcome of lung adenocarcinoma patients with gefitinib treatment[J].ANNALS OF ONCOLOGY.2018,29:7-7.doi:10.1093/annonc/mdy318.002.
APA：
Zhang, N.,Yang, M.,Zhang, L.,Liu, J.&Xing, H..(2018).The functional MDM4 genetic variant is associated with clinical outcome of lung adenocarcinoma patients with gefitinib treatment.ANNALS OF ONCOLOGY,29,
MLA：
Zhang, N.,et al."The functional MDM4 genetic variant is associated with clinical outcome of lung adenocarcinoma patients with gefitinib treatment".ANNALS OF ONCOLOGY 29.(2018):7-7
医学